Every IND has a story behind it that never makes it into the submission itself: the decisions that mattered, the lessons learned, the dozens of team decisions and hand-offs made under rounds of iteration.
For lean biotech teams, compiling an IND is both a marathon and a sprint. AI tools offer fuel for not only generating content faster, but connecting program knowledge in a repeatable way.
Join the webinar to hear practitioner perspectives on:
What the road to IND revealed about where AI accelerates regulatory teams, allowing them to focus their expertise where it matters most
Building institutional knowledge that survives beyond a single submission
What they'd do differently next time, with practical takeaways for teams starting their own IND journey
